ArticleOPEN ACCESS

Quest of biomarkers for venetoclax-treated CLL

Blood
DOI: 10.1182/blood.2019001189
4Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Roberts et al expand our understanding of prognostic biomarkers predicting the duration of remission in relapsed/refractory chronic lymphocytic leukemia (CLL) treated with venetoclax.

Cite

CITATION STYLE

APA

Rossi, D. (2019, July 11). Quest of biomarkers for venetoclax-treated CLL. Blood. American Society of Hematology. https://doi.org/10.1182/blood.2019001189

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free